(Q38172567)

30 August 2017

title

Roadmap of miR-122-related clinical application from bench to bedside (English)

1 reference

30 August 2017

Zhihua Qiu

1

1 reference

30 August 2017

Yimin Dai

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

20 December 2013

1 reference

Expert Opinion on Investigational Drugs

30 August 2017

published in

1 reference

30 August 2017

volume

23

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

347-355

1 reference

The emerging roles of microRNAs in CNS injuries

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Natural RNA circles function as efficient microRNA sponges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA replacement therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Strategies to determine the biological function of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA-223 is neuroprotective by targeting glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Cell signalling by microRNA165/6 directs gene dose-dependent root cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

DNA methylomes, histone codes and miRNAs: tying it all together

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Pattern formation via small RNA mobility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Identification of tissue-specific microRNAs from mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Intranasal delivery of stem cells to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122, a paradigm for the role of microRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

HCV treatment--no more room for interferonologists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Structural map of a microRNA-122: hepatitis C virus complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Site-specific interaction of the murine pre-replicative complex with origin DNA: assembly and disassembly during cell cycle transit and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122 continues to blaze the trail for microRNA therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Can tobacco use promote HCV-induced miR-122 hijacking and hepatocarcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

The effects of hepatitis C virus core protein on the expression of miR-122 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Inhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Involvement of microRNAs in dioxin-induced liver damage in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122 regulates hepatic lipid metabolism and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Circulating microRNAs in hepatitis B virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Serum microRNA-122 predicts survival in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Telaprevir for previously treated chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Increased skeletal muscle-specific microRNA in the blood of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA miR-122 as a therapeutic target for oligonucleotides and small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

MicroRNA: Not Far from Clinical Application in Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2014.867327

10.1517/13543784.2014.867327

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference